Treatment of Bronchial Asthma (Zeequn Nafas) with Unani Medicine

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2023
INTERVENTION: Intervention1: Safoof Damma Haldiwaala: 5 gm to be given orally twice daily for 51 days Control Intervention1: Salbutamol: 2mg to be given orally twice daily for 51 days CONDITION: Health Condition 1: J989‐ Respiratory disorder, unspecified PRIMARY OUTCOME: Improvement in ACQ score, Pulmonary function test in cases of Zeeq un NafasTimepoint: 17 DAYS SECONDARY OUTCOME: Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and after 51 days INCLUSION CRITERIA: (1) Patients of Bronchial Asthama for atleast 6 months having following symptoms: wheeze, Shortness of Breath, Chest Tightness and cough that vary over time and in intensity, Expiratory airflow limitation as suggested by a decreased FEV1. (2) Objective evidence for reversible airway obstruction (â?¥12% and â?¥200 mL change in FEV1 and/or a 25% and 60 L/min change in PEFR) either spontaneously or after treatment. (3) patients with Asthma Control Questionnaire Score >1.5
Epistemonikos ID: d14e9b1232a25354d51dae8b95a982e44fdda892
First added on: Feb 20, 2024